Loading insider details...
Latest Form 4 (Sep 17, 2026): Exercise/Conversion of 18,500 VERA shares, $53.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 17, 2026 | Vera Therapeutics, Inc. (VERA) | Exercise/Conversion | 18,500 | $53.6K |
| Sep 4, 2026 | Vera Therapeutics, Inc. (VERA) | Exercise/Conversion | 18,500 | $53.6K |
| Aug 12, 2026 | Vera Therapeutics, Inc. (VERA) | Exercise/Conversion | 46,250 | $134.0K |
| Aug 12, 2026 | Vera Therapeutics, Inc. (VERA) | Exercise/Conversion | 18,500 | $53.6K |
| Aug 12, 2026 | Vera Therapeutics, Inc. (VERA) | Exercise/Conversion | 18,500 | $53.6K |
| Apr 15, 2026 | Vera Therapeutics, Inc. (VERA) | Sale | 14,130 | $617.0K |
| Feb 26, 2026 | Vera Therapeutics, Inc. (VERA) | Sale | 16,925 | $710.6K |
| Feb 7, 2026 | Vera Therapeutics, Inc. (VERA) | Grant/Award | 68,800 | n/a |
| Feb 27, 2025 | Vera Therapeutics, Inc. (VERA) | Sale | 10,613 | $296.0K |
| Feb 20, 2025 | Vera Therapeutics, Inc. (VERA) | Grant/Award | 80,750 | n/a |